PRAH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PRAH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PRA Health Sciences's average Accounts Receivable for the three months ended in Mar. 2021 was $625 Mil. PRA Health Sciences's Revenue for the three months ended in Mar. 2021 was $934 Mil. Hence, PRA Health Sciences's Days Sales Outstanding for the three months ended in Mar. 2021 was 61.06.
The historical rank and industry rank for PRA Health Sciences's Days Sales Outstanding or its related term are showing as below:
During the past 9 years, PRA Health Sciences's highest Days Sales Outstanding was 70.04. The lowest was 55.59. And the median was 56.72.
PRA Health Sciences's Days Sales Outstanding increased from Mar. 2020 (59.82) to Mar. 2021 (61.06).
The historical data trend for PRA Health Sciences's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRA Health Sciences Annual Data | |||||||||||||||||||
Trend | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | ||||||||||
Days Sales Outstanding | Get a 7-Day Free Trial | 57.98 | 59.96 | 56.85 | 56.49 | 67.25 |
PRA Health Sciences Quarterly Data | ||||||||||||||||||||
Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | |
Days Sales Outstanding | Get a 7-Day Free Trial | 59.82 | 67.72 | 63.33 | 62.60 | 61.06 |
For the Diagnostics & Research subindustry, PRA Health Sciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, PRA Health Sciences's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where PRA Health Sciences's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
PRA Health Sciences's Days Sales Outstanding for the fiscal year that ended in Dec. 2020 is calculated as
Days Sales Outstanding (A: Dec. 2020 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2019 ) | + | Accounts Receivable (A: Dec. 2020 )) | / | count ) | / | Revenue (A: Dec. 2020 ) | * | Days in Period |
= | ( (512.061 | + | 661.036) | / | 2 ) | / | 3183.365 | * | 365 |
= | 586.5485 | / | 3183.365 | * | 365 | ||||
= | 67.25 |
PRA Health Sciences's Days Sales Outstanding for the quarter that ended in Mar. 2021 is calculated as:
Days Sales Outstanding (Q: Mar. 2021 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2020 ) | + | Accounts Receivable (A: Mar. 2021 )) | / | count ) | / | Revenue (A: Mar. 2021 ) | * | Days in Period |
= | ( (661.036 | + | 588.672) | / | 2 ) | / | 933.775 | * | 365 / 4 |
= | 624.854 | / | 933.775 | * | 365 / 4 | ||||
= | 61.06 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRA Health Sciences (NAS:PRAH) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of PRA Health Sciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael J. Bonello | officer: EVP & CFO | 4130 PARKLAKE AVENUE, SUITE 400, RALEIGH NY 27612 |
Shannon Colin | director, officer: President & CEO | PRA INTERNATIONAL 12120 SUNSET HILLS ROAD, SUITE 600 RESTON VA 20190 |
Christopher L Gaenzle | officer: EVP, CAO & General Counsel | C/O INC RESEARCH HOLDINGS, INC., 3201 BEECHLEAF COURT, SUITE 600, RALEIGH NC 27604 |
Glen D. Stettin | director | C/O EXPRESS SCRIPTS HOLDING COMPANY, ONE EXPRESS WAY, ST. LOUIS MO 63121 |
Alexander George Dickinson | director | 31542 CATALINA AVE LAGUNA BEACH CA 92651 |
Jeffrey T Barber | director | 6501 WESTON PARKWAY, SUITE 200 CARY NC 27513 |
Matthew P. Young | director | C/O JAZZ PHARMACEUTICALS PLC, 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN L2 4 L2 |
Linda S Grais | director | 86 ALEJANDRA AVE, ATHERTON CA 94027 |
James C Momtazee | director | 2884 SAND HILL ROAD, SUITE 100, MENLO PARK CA 94025 |
George R Roberts | 10 percent owner | C/O KOHLBERG KRAVIS ROBERTS & CO. L.P., 2800 SAND HILL ROAD, MENLO PARK CA 94025 |
Kkr Pra Investors Gp Ii Llc | 10 percent owner | 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019 |
Kkr Pra Investors L.p. | 10 percent owner | 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019 |
Kkr Pra Investors Gp Llc | 10 percent owner | 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019 |
Kkr North America Xi Ltd | 10 percent owner | KOHLBERG KRAVIS ROBERTS & CO. L.P., 9 WEST 57TH STREET, SUITE 4200, NEW YORK NY 10019 |
Kkr North America Fund Xi L.p. | 10 percent owner | C/O KOHLBERG KRAVIS ROBERTS & CO. L.P., 30 HUDSON YARDS, NEW YORK NY 10001 |
From GuruFocus
By Marketwired Marketwired • 09-18-2020
By Marketwired Marketwired • 02-24-2021
By Marketwired Marketwired • 02-04-2021
By Marketwired Marketwired • 04-14-2020
By PRNewswire PRNewswire • 02-24-2021
By Marketwired Marketwired • 09-16-2020
By Marketwired Marketwired • 10-08-2020
By GlobeNewswire GlobeNewswire • 10-07-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.